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Diagnosis: Low SpO 2 due to an abnormal oxygen hemoglobin dissociation curve
The arterial oxygen saturation (SaO 2 ) is measured noninvasively by pulse oximetry (SpO 2 ) to detect arterial oxygen desaturation and hypoxemia. The SaO 2 is usually defined as the amount of oxyhemoglobin (O 2 Hb) divided by the sum of the O 2 Hb and the deoxygenated or reduced hemoglobin (RHb).
SaO 2 % = (O 2 Hb) × 100/ (O 2 Hb + RHb) (Equation 1) At normal arterial oxygen levels, only a small amount of oxygen is dissolved in the blood and most of the oxygen-carrying capacity depends on the amount of hemoglobin bound to oxygen. However, determining the oxygen-carrying capacity of hemoglobin is complicated by the fact that both carboxyhemoglobin (COHb) and methemoglobin (metHb) are forms of circulating hemoglobin that do not bind oxygen. The true fraction of hemoglobin bound to oxygen (FO 2 Hb) then depends on the fraction (%) of carboxyhemoglobin (FCOHb) and methemoglobin (FMetHb) as well as the fraction of reduced hemoglobin (FRHb).
FO 2 Hb + FRHb + FCOHb + FMetHb = 100% (Equation 2) For example, if the FO 2 Hb = 85%, FCOHb = 8%, FMetHb = 1%, then the FRHb is 6%. Using these numbers, the SaO 2 equals 85 × 100/(85 + 6) or 93%, which is considerably higher than an FO 2 Hb of 85%. The FO 2 Hb and the amount of hemoglobin are the main determinants of the oxygen-carrying capacity of the blood. The difference between the SaO 2 and the FO 2 Hb is primarily determined by the amount of COHb and MetHb. The FO 2 Hb is sometimes called the fractional saturation, and the SaO 2 , the functional or effective saturation.
The above 4 fractions of hemoglobin can be accurately measured by co-oximeters that measure the absorption of 4 or more wavelengths of electromagnetic radiation by a sample of arterial blood.
1 This is possible because the 4 forms of hemoglobin differ in their absorption for the different wavelengths of radiation. In contrast, pulse oximetry 1 uses only 2 wave lengths, 660 nm (red) and 940 nm (infrared) to measure the O 2 Hb and RHb. The absorption of radiation at 660 nm is much greater with RHb than with O 2 Hb, whereas O 2 Hb absorbs more radiation at 940 nm ( Figure  2A ). Pulse oximetry is based on the empiric observation that the ratio (R) of absorbance at the 2 wavelengths is related to the oxygen saturation ( Figure 2B ). This relationship (calibration curve) is determined experimentally by determining R at varying oxygen saturations. To specifically determine the absorbance of arterial blood, the AC (pulse added absorbance) at each wavelength is divided by the DC (background absorbance) to account for the effect of the absorption of the radiation by venous blood and tissue. Carboxyhemoglobin has about the same absorbance at 660 as oxyhemoglobin and, if present, increases the measured SpO 2 value. In normal individuals, FCOHb is 2% or less but can be 8% or more in cigarette smokers. Patients with SCD often have FCOHb values of 4% or more due to production of carbon dioxide from chronic hemolysis. Based on a canine experiment, 1 it has been estimated that a pulse oximeter sees COHb as 90% O 2 Hb and 10% RHb. For example, from the following values (FO 2 Hb = 85%, COHb = 4%, MetHb = 0%, RHb = 11%), one can estimate the SpO 2 as 88.6% (85 + .9 × 4). This is essentially the same as the SaO 2 computed from equation 1 for these values. As noted below, SpO 2 measurements in patients with SCD who have carboxyhemoglobinemia often show fairly good agreement with the SaO 2 but overestimate the FO 2 Hb.
Inference about the arterial oxygen pressure (PaO 2 ) based on the SaO 2 requires a knowledge of the factors that can affect the oxyhemoglobin dissociation curve (Figure 3) . The oxyhemoglobin dissociation curve is shifted to the right with increases in body temperature, PaCO 2 , 2-3DPG (a product of glycolysis), or H + ion concentration (acidemia). The opposite changes in the factors shift the curve to the left. CO can not only bind a portion of the Hb (preventing oxygen binding) but can shift the oxyhemoglobin dissociation curve of the remaining Hb to the left. Variant hemoglobins can shift the position of the curve to the left or right from that associated with normal hemoglobin (Hb A). In dilute solution, sickle hemoglobin (HbS) has similar affinity for oxygen as hemoglobin A. (They differ by only a single peptide.) However, at the higher hemoglobin concentration present in red cells, deoxygenated sickle hemoglobin forms polymers that have a low affinity for oxygen. 2, 3 The net effect is a rightward shift in the oxyhemoglobin dissociation curve for Hb S (Figure 3) . The position of the oxyhemoglobin dissociation curve is often defined by the P 50 , which is the PO 2 corresponding to an SaO 2 of 50%. For Hb A, the P 50 is 26 mm Hg but is 42 to 56 mm Hg in patients with SCD. 3 This means that, for a given SaO 2 , the PaO 2 is higher in patients with SCD than would be expected based on the normal oxyhemoglobin dissociation curve. The amount of right shift varies considerably between patients with SCD and can be influenced by transfusion with blood (Hb A).
Given the similar structures of Hb A and Hb S, one might expect similar absorption at the wavelengths of electromagnetic radiation used for oximetry. A number of studies have assessed the ability of pulse oximetry (SpO 2 ) to estimate the SaO 2 and to detect hypoxemia in patients with SCD. In general, the SpO 2 exceeds the FO 2 Hb but is fairly close to the SaO 2 . Craft and coworkers 4 found that the SpO 2 exceeded the FO 2 Hb by a mean of approximately 7%. Ortiz et al 5 studied 22 patients with SCD admitted with a vaso-occlusive episode. The mean SpO 2 exceeded the FO 2 Hb (90.4% vs 87.1%) but approximated the SaO 2 (91.5%). In this study, the COHb was 3.8%, and the P 5O was 35 mm Hg. Blaisdell et al 6 found that 33% of a group of patients with SCD who were predicted to be hypoxemic with SpO 2 measurements less than 93% actually had PaO 2 values greater than 70 mm Hg. Bromberg and coworkers 7 studied 9 patients with SCD with SpO 2 values ranging from 75% to 90%, and none had an arterial PO 2 less than 70 mm Hg.
In the current patient, an arterial blood gas was obtained at the end of the study while the patient was awake and breathing room air. The values were a pH of 7.44, a PaCO 2 of 37 mm Hg, a PaO 2 of 90 mmHg, and a HCO 3 of 25.3 mMol/L. The SpO 2 measurement at same time was 92%. Co-oximetry was not performed on the sample, but prior measurements had shown FCOHb and FMetHb values of 4% and 1%, respectively. Given the high PO 2 corresponding to an SpO 2 of 92%, one can conclude that the low SpO 2 in Figure 1 was not due to hypoxemia but, rather, to the patient's abnormal hemoglobin. 
